The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called synovial sarcoma.
Partnerships are key to driving digital healthcare transformation in US, say experts – Pharmaceutical Technology
Share this article Credit: Shutterstock Partnerships between different stakeholders in the healthcare industry are crucial for driving healthcare transformation. Stakeholders can include diverse groups –